SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19
C Hirsch, YS Park, V Piechotta, KL Chai… - Cochrane Database …, 2022 - cochranelibrary.com
Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19 (systematic review)
C Hirsch, YS Park, V Piechotta… - Cochrane Database …, 2022 - research.monash.edu
Background: Monoclonal antibodies (mAbs) are laboratory-produced molecules derived
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
C Hirsch, YS Park, V Piechotta, KL Chai… - The Cochrane …, 2022 - europepmc.org
Background Monoclonal antibodies (mAbs) are laboratory-produced molecules derived from
the B cells of an infected host. They are being investigated as potential prophylaxis to …
the B cells of an infected host. They are being investigated as potential prophylaxis to …
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
C Hirsch, SJ Valk, V Piechotta… - The Cochrane …, 2021 - researchportal.ukhsa.gov.uk
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as
follows:. To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs …
follows:. To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs …
[引用][C] SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19
Cochrane Haematology Group… - Cochrane Database …, 1996 - cochranelibrary.com
Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
C Hirsch, YS Park, V Piechotta… - The Cochrane …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Monoclonal antibodies (mAbs) are laboratory-produced molecules derived from
the B cells of an infected host. They are being investigated as potential prophylaxis to …
the B cells of an infected host. They are being investigated as potential prophylaxis to …
[HTML][HTML] SARS‐CoV‐2‐neutralising monoclonal antibodies to prevent COVID‐19
C Hirsch, YS Park, V Piechotta, KL Chai… - The Cochrane …, 2022 - ncbi.nlm.nih.gov
Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
C Hirsch, SJ Valk, V Piechotta, KL Chai… - Cochrane Database of …, 2021 - ora.ox.ac.uk
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as
follows: To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including …
follows: To assess the effectiveness and safety of SARS-CoV-2-neutralising mAbs, including …
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19.
C Hirsch, YS Park, V Piechotta, KL Chai, LJ Estcourt… - 2022 - cabidigitallibrary.org
Background: Monoclonal antibodies (mAbs) are laboratory-produced molecules derived
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
from the B cells of an infected host. They are being investigated as potential prophylaxis to …
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
C Hirsch, YS Park, V Piechotta… - … Database Syst Rev., 2022 - kups.ub.uni-koeln.de
Background Monoclonal antibodies (mAbs) are laboratory-produced molecules derived from
the B cells of an infected host. They are being investigated as potential prophylaxis to …
the B cells of an infected host. They are being investigated as potential prophylaxis to …